RxSight, Inc. Hits 52-Week Low at $5.31 Amid Ongoing Struggles

RxSight, Inc., a microcap company in the Electronics & Appliances industry, has reached a new 52-week low of USD 5.31 as of May 29, 2026. This significant decline marks a staggering 90.96% drop in the stock's performance over the past year, contrasting sharply with the S&P 500's gain of 28.21% during the same period. The company's market capitalization stands at USD 309 million, and it has reported negative results for the last four consecutive quarters. Key financial metrics indicate a challenging environment, with a return on equity of -12.95% and a debt-to-equity ratio of -0.82. Additionally, the inventory turnover ratio is at its lowest, recorded at just 1 time, while the debtors turnover ratio is also low at 4.77 times. With a price-to-book ratio of 1.12 and no dividend yield, RxSight's financial indicators reflect a company facing significant hurdles. The stock's previous 52-week high was USD 16.36, highlighting the extent of its recent decline.